Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy

24Citations
Citations of this article
71Readers
Mendeley users who have this article in their library.

Abstract

In tropical regions millions of people still live at risk of malaria infection. Indeed the emergence of resistance to chloroquine and other drugs in use in these areas reinforces the need to implement alternative prophylactic strategies. Genistein is a naturally occurring compound that is widely used as a food supplment and is thought to be effective in countering several pathologies. Results presented here show that genistein inhibits liver infection by the Plasmodium parasite, the causative agent of malaria. In vitro, genistein decreased the infection rates of both mouse and human hepatoma cells by inhibiting the early stages of the parasite's intracellular development. Oral or intraperitoneal administration of genistein decreased the liver parasite load of P. berghei-infected mice. Moreover, mice fed on a genistein-supplemented diet showed a significant reduction in Plasmodium liver infection as well as a reduced blood parasitemia and partial protection from severe disease. Since genistein is a safe, low-cost, natural compound that can be used permanently in a diet, we propose its use as a prophylactic agent against malaria for endemic populations and long-time travelers. © 2008 Cunha-Rodrigues et al.

Cite

CITATION STYLE

APA

Cunha-Rodrigues, M., Portugal, S., Prudêncio, M., Gonçalves, L. A., Casalou, C., Buger, D., … Mota, M. M. (2008). Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy. PLoS ONE, 3(7). https://doi.org/10.1371/journal.pone.0002732

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free